Cargando…
Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan
BACKGROUND: Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide. In Afghanistan, where most births take place at home without the assistance of a skilled birth attendant, there is a need for options to manage PPH in community-based settings. Misoprostol, a uterotonic tha...
Autores principales: | Abbas, Dina F., Mirzazada, Shafiq, Durocher, Jill, Pamiri, Shahfaqir, Byrne, Meagan E., Winikoff, Beverly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275481/ https://www.ncbi.nlm.nih.gov/pubmed/32503556 http://dx.doi.org/10.1186/s12978-020-00933-8 |
Ejemplares similares
-
Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostol
por: Ditai, James, et al.
Publicado: (2017) -
Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012) -
High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010) -
How well do postpartum blood loss and common definitions of postpartum hemorrhage correlate with postpartum anemia and fall in hemoglobin?
por: Anger, Holly, et al.
Publicado: (2019) -
Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)